CDL Karachi earns WHO prequalification, boosting Pakistan’s drug testing standards

ISLAMABAD, (APP - UrduPoint / Pakistan Point News - 29th Apr, 2026) The Ministry of National Health Services, Regulations and Coordination (NHSR&C) announced that the Central Drugs Laboratory (CDL) Karachi, a statutory facility of the Drug Regulatory Authority of Pakistan (DRAP), has secured World Health Organization (WHO) prequalification, marking a major milestone for the country’s healthcare system.

The certification confirmed that DRAP’s testing services meet stringent global standards, ensuring that medicines assessed at the facility are safe, effective and of high quality.

Federal Minister for National Health Services Syed Mustafa Kamal congratulated DRAP leadership and the CDL technical team, calling the achievement a key step in advancing regulatory excellence and health sector reforms.

He described the development as a “historic moment,” highlighting the government’s shift toward a preventive, quality-focused healthcare system. He said ensuring globally compliant drug testing serves as a critical safeguard for public health.

The minister added that the recognition would also strengthen Pakistan’s pharmaceutical industry by enhancing international credibility and supporting the “Made in Pakistan” brand in global markets.

The ministry reiterated its commitment to modernizing the national regulatory framework and supporting DRAP in achieving WHO global benchmarking, aiming to curb substandard and counterfeit medicines.

Officials said the milestone reflects progress toward ensuring safe, effective and quality healthcare for all citizens.